Prescription drug marketing directed to Vermont prescribers is reported to require disclosure of the drug's price and its price relationship to other drugs in the same therapeutic class; the statute needs verification before the rule is enabled.
From January 1, 2028, Vermont bars targeted advertising to and sale of data of known 13-17-year-olds, requires consent to process or sell sensitive data, requires a linked privacy notice with clear disclosure of sale and targeted advertising plus an opt-out and opt-out preference signals, and bars geofencing health facilities and selling consumer health data without consent regardless of business size.